AtonRa Partners’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,035
| Closed | -$74.3K | – | 118 |
|
|
2023
Q1 | $74.3K | Sell |
13,035
-1,877
| -13% | -$10.7K | 0.11% | 121 |
|
|
2022
Q4 | $150K | Sell |
14,912
-4,034
| -21% | -$40.7K | 0.19% | 111 |
|
|
2022
Q3 | $425K | Sell |
18,946
-528
| -3% | -$11.8K | 0.42% | 99 |
|
|
2022
Q2 | $483K | Sell |
19,474
-1,223
| -6% | -$30.3K | 0.44% | 105 |
|
|
2022
Q1 | $802K | Buy |
20,697
+4,559
| +28% | +$177K | 0.44% | 89 |
|
|
2021
Q4 | $944K | Buy |
16,138
+1,644
| +11% | +$96.2K | 0.33% | 95 |
|
|
2021
Q3 | $859K | Sell |
14,494
-8,717
| -38% | -$517K | 0.29% | 105 |
|
|
2021
Q2 | $2.01M | Buy |
23,211
+1,344
| +6% | +$117K | 0.74% | 63 |
|
|
2021
Q1 | $1.8M | Sell |
21,867
-1,540
| -7% | -$127K | 0.8% | 52 |
|
|
2020
Q4 | $2.13M | Buy |
+23,407
| New | +$2.13M | 1.04% | 48 |
|